Myriad morcells, 4 mg
A2033 identifies Myriad Morcells in 4 mg units; A2032 identifies Myriad Matrix by square centimeter. Use the code matching the product supplied.
CMS RVU26D · Effective 2026-10-01
Reports Myriad Matrix wound product by square centimeter when supplied for application to a wound during a qualifying primary wound procedure. Compare A2032 office and facility rates across CMS payment localities in Maine.
Amounts below use the non-QP conversion factor for participating physicians. These are base physician payments before claim-level adjustments, not patient costs or total hospital charges.
Maine has 2 payment localities in this comparison. Use the service location to choose the applicable amount. These are the supported base rates for the 2 payment areas shown below, using the same CMS release.
$117.08–$126.11
2 of 2 localities have a supported rate.
No supported rate
These are locality ranges, not averages or address-specific quotes. A facility-setting amount covers the physician service; it does not include a hospital’s separate bill. Choose a locality below to inspect its calculation, compare other payment areas, or price a percentage of Medicare.
Wound care
Reports Myriad Matrix wound product by square centimeter when supplied for application to a wound during a qualifying primary wound procedure.
A2032 identifies Myriad Matrix supplied for wound care, measured by surface area. Clinicians may apply it to a wound bed in a wound clinic or outpatient procedural setting, including during care of chronic ulcers or surgical wounds. The wound application is performed by the treating clinician; this code identifies the product rather than the application work itself.
Report the quantity in square centimeters with the applicable primary wound procedure. Documentation should identify the product, treated wound, area represented by the units, and the related procedure. A2032 is an add-on code and is paid within the primary procedure's global period. It is technical-component-only; a separate code covers interpretation.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Office rates for Maine, from the same CMS release.
Myriad morcells, 4 mg
A2033 identifies Myriad Morcells in 4 mg units; A2032 identifies Myriad Matrix by square centimeter. Use the code matching the product supplied.
15271 reports a primary wound application procedure for its specified wound sites; A2032 reports the Myriad Matrix product and must accompany a primary procedure.
15275 reports a primary wound application procedure for specified sites such as the face, scalp, or hands; A2032 identifies the product used with the procedure.
Find the payment area for your service address, then open its rate page for calculation inputs, release history and the percentage-of-Medicare tool. A city may cross payment-area boundaries; the ZIP lookup above helps resolve the location.
2 of 2 payment localities
Office / nonfacility
$117.08
Facility
Unavailable
Office / nonfacility
$126.11
Facility
Unavailable
Fee-sheet and API access are in early access. Tell us which codes and locations your team needs.
A2032 must be reported with a primary wound procedure, such as an applicable skin-substitute application procedure. It is paid within that procedure's global period.
The code is measured per square centimeter. Keep documentation showing the Myriad Matrix product and the wound area represented by the reported quantity.
No. A2032 is technical-component-only; a separate code covers interpretation.
A2032 identifies Myriad Matrix by square centimeter, while A2033 identifies Myriad Morcells by a 4 mg unit. Select the code matching the product supplied.
No. It is an add-on code and must accompany a primary procedure.
FeeBase calculates base physician payments from CMS work, practice-expense, and malpractice RVUs, adjusted by each locality’s geographic indices and the applicable conversion factor. Unavailable or separately priced services are labeled rather than assigned a made-up amount.
Source: RVU26D. Effective 2026-10-01 through the day before 2027-01-01.